Interpretable neural network for risk stratification and drug target discovery based on PBMC transcriptomes
An interpretable AI tool uses blood immune cells to predict disease risk and identify treatment targets, combining prediction with scientific insight.
This study develops an interpretable neural network applied to PBMC transcriptomes for risk stratification and drug target discovery, providing a clinically actionable AI tool grounded in blood-based molecular data. The interpretable architecture enables identification of mechanistically meaningful targets beyond black-box prediction.
What the study was
- Study design
- Computational/ML study with PBMC transcriptomic data
- Population
- Patient cohorts with PBMC transcriptomic data
- Category
- Diagnostics
- Maturity
- Exploratory
- Journal
- iScience
Why it surfaced
Novel interpretable neural network for blood-based risk stratification; relevant to CBC/ML and AI diagnostics watchlists.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.